Intratumoral antigen signaling traps CD8 + T cells to confine exhaustion to the tumor site.
Munetomo TakahashiTsz Y SoVitalina Chamberlain-EvansRobert HughesJuan Carlos Yam-PucKatarzyna KaniaMichelle RuhleTiffeney MannMartijn J SchuijsPaul CouplandDean John NaisbittTimotheus Y F HalimPaul A LyonsPietro LióRahul RoychoudhuriKlaus OkkenhaugDavid J AdamsKenneth G C SmithDuncan Ian JodrellMichael A ChapmanJames E D ThaventhiranPublished in: Science immunology (2024)
Immunotherapy advances have been hindered by difficulties in tracking the behaviors of lymphocytes after antigen signaling. Here, we assessed the behavior of T cells active within tumors through the development of the antigen receptor signaling reporter (AgRSR) mouse, fate-mapping lymphocytes responding to antigens at specific times and locations. Contrary to reports describing the ready egress of T cells out of the tumor, we find that intratumoral antigen signaling traps CD8 + T cells in the tumor. These clonal populations expand and become increasingly exhausted over time. By contrast, antigen-signaled regulatory T cell (T reg ) clonal populations readily recirculate out of the tumor. Consequently, intratumoral antigen signaling acts as a gatekeeper to compartmentalize CD8 + T cell responses, even within the same clonotype, thus enabling exhausted T cells to remain confined to a specific tumor tissue site.